The invention discloses a
CRISPR / Cas9-gRNA targeting sequence pair, a
plasmid and an HD model of HTT, and relates to the field of
biotechnology. The targeting sequence pair of the invention comprisesan L sequence and an R sequence. The
base sequence of the L sequence is shown as SEQ ID NO.1. The
base sequence of the R sequence is shown as SEQ ID NO.2. The targeting
plasmid of the invention comprises a first vector
plasmid and the above-mentioned targeting sequence pair. The targeting sequence pair is constructed into the first vector plasmid. The HD
cell model of the invention is obtained byco-transfecting cells with PolyQ Donor plasmids and the above-mentioned targeting plasmids. By using differentiated
neuron cells as a carrier to construct the HD
cell model, the invention provides a research platform for exploring the influences or changes of mHtt
protein on the internal environment of differentiated
nerve cells, and studying the changes of various
signal pathways, metabolic pathways and
intracellular homeostasis caused by mHtt
protein in differentiated neuronal cells.